Further studies found that when oxaliplatin is used in combination with cannabidiol (CBD), it significantly reduces the phosphorylation levels of NOS3 in tumor cells and leads to the production of excess reactive oxygen species (ROS), thereby inducing autophagy in CRC cells and enhancing their sensitivity to oxaliplatin (83). This evidence concerns the gene NOS3 and colorectal carcinoma.